Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: BLL003
MIFTS: 49

Bell's Palsy

Categories: Eye diseases, Infectious diseases, Neuronal diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Bell's Palsy

About this section

MalaCards integrated aliases for Bell's Palsy:

Name: Bell's Palsy 12 74 52 53 42 15 17
Bell Palsy 12 52 43 71 32
Facial Palsy 52 29 6
Facial Paralysis 52 71
Facial Cranial Nerve Paralysis 52
Idiopathic Facial Palsy 52
Refrigeration Palsy 52
Facial Nerve Palsy 52
Bell's Palsy 12
Antoni's Palsy 52

Classifications:

MalaCards categories:
Global: Rare diseases Infectious diseases
Anatomical: Neuronal diseases Eye diseases
See all MalaCards categories (disease lists)
ICD10: 32


External Ids:

Disease Ontology 12 DOID:12506
ICD9CM 34 351.0
MeSH 43 D020330
SNOMED-CT 67 79359001
ICD10 32 G51.0
UMLS 71 C0015469 C0376175
Sources

Summaries for Bell's Palsy

About this section
NINDS : 53 Bell's palsy is a form of temporary facial paralysis resulting from damage or trauma to the 7th cranial nerve, one of the facial nerves. It is the most common cause of facial paralysis. Generally, Bell's palsy affects only one side of the face, but it can affect both sides. Symptoms vary among individuals and include sudden weakness on one side of the face, drooping eyelid or corner of the mouth, drooling, inability to close the eye or mouth, altered taste, and excessive tearing in the eye. Symptoms appear suddenly and reach their peak within 72 hours. Bell's palsy can range in severity from mild weakness to total paralysis, and can cause significant facial distortion. The exact cause of Bell's palsy isn't known, but many scientists believe that reactivation of a dormant viral infection can cause the facial nerve to swell and become inflamed. Several other conditions can cause facial paralysis that might be diagnosed as Bell's palsy. The disorder can affect anyone at any age. Risk factors include pregnancy, preeclampsia, obesity, hypertention, diabetes, and upper respiratory ailments.

MalaCards based summary : Bell's Palsy, also known as bell palsy, is related to herpes zoster and miller fisher syndrome, and has symptoms including seizures, tremor and muscle weakness. An important gene associated with Bell's Palsy is HS1BP3 (HCLS1 Binding Protein 3), and among its related pathways/superpathways is NOD-like receptor signaling pathway. The drugs Prednisolone and Methylprednisolone have been mentioned in the context of this disorder. Affiliated tissues include eye, bone and testes.

Disease Ontology : 12 A facial paralysis resulting from dysfunction in the cranial nerve VII (facial nerve).

NIH Rare Diseases : 52 Bell's palsy is a form of temporary facial paralysis which results from damage or trauma to one of the facial nerves. This disorder is characterized by the sudden onset of facial paralysis that often affects just one side and can cause significant facial distortion. Symptoms vary, but may include twitching, weakness, drooping eyelid or corner of the mouth, drooling, dry eye or mouth, impairment of taste, and excessive tearing in the eye. While the exact cause is unknown, many researchers believe that a virus may lead to swelling of the 7th cranial nerve. Steroids, such as prednisone , may reduce the inflammation and swelling. Other medications used to treat Bell's palsy include acyclovir (to fight viral infections) and aspirin, acetaminophen, or ibuprofen (to relieve pain). Physical therapy , facial massage and acupuncture have also been used.

MedlinePlus : 42 Bell's palsy is the most common cause of facial paralysis. It usually affects just one side of the face. Symptoms appear suddenly and are at their worst about 48 hours after they start. They can range from mild to severe and include Twitching Weakness Paralysis Drooping eyelid or corner of mouth Drooling Dry eye or mouth Excessive tearing in the eye Impaired ability to taste Scientists think that a viral infection makes the facial nerve swell or become inflamed. You are most likely to get Bell's palsy if you are pregnant, diabetic or sick with a cold or flu. Three out of four patients improve without treatment. With or without treatment, most people begin to get better within 2 weeks and recover completely within 3 to 6 months. NIH: National Institute of Neurological Disorders and Stroke

Wikipedia : 74 Bell's palsy is a type of facial paralysis that results in an inability to control the facial muscles on... more...

Sources

Related Diseases for Bell's Palsy

About this section

Diseases related to Bell's Palsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 813)
# Related Disease Score Top Affiliating Genes
1 herpes zoster 30.8 IFNA1 CD40LG CD4
2 miller fisher syndrome 30.2 PMP22 CD40LG
3 pityriasis rosea 30.1 CD40LG CD4
4 mumps 30.1 MX1 IL2RA IFNA1 CD40LG
5 syphilitic meningitis 30.0 CD40LG CD4
6 parotitis 30.0 CD40LG CD4
7 mononeuritis multiplex 30.0 PMP22 CD40LG CD4
8 plexopathy 30.0 PMP22 CD40LG
9 hairy cell leukemia 29.9 IL2RA IFNA1 CD40LG
10 secondary syphilis 29.9 CD40LG CD4
11 asymptomatic neurosyphilis 29.9 CD40LG CD4
12 demyelinating disease 29.9 PMP22 IFNA1 CD40LG CD4
13 west nile encephalitis 29.9 CD40LG CD4
14 exanthema subitum 29.8 CD40LG CD4
15 cranial nerve palsy 29.8 CD40LG CD4 ANTXR2
16 chlamydia pneumonia 29.8 CD40LG CD4
17 uveoparotid fever 29.8 CD40LG CD4
18 leprosy 3 29.7 PRKN CD40LG CD4
19 facial paralysis 29.7 MTRNR2L5 MARVELD1 LIPN HOXB1 FKBP4 CD40LG
20 xerophthalmia 29.7 MTRNR2L5 CD40LG CD4
21 granulomatous hepatitis 29.7 CD40LG CD4
22 sarcoidosis 1 29.7 IL2RA CD40LG CD4
23 viral hepatitis 29.7 MX1 IFNA1 CD40LG
24 neuroretinitis 29.7 CD40LG CD4
25 cat-scratch disease 29.7 CD40LG CD4
26 congenital syphilis 29.6 CD40LG CD4
27 trichinosis 29.6 CD40LG CD4
28 parotid disease 29.6 CD40LG CD4
29 acquired immunodeficiency syndrome 29.5 IL2RA IFNA1 CD40LG CD4
30 immune deficiency disease 29.4 IL2RA IFNA1 CD40LG CD4
31 multiple sclerosis 29.3 MX1 IL2RA IFNA1 CD40LG CD4
32 peripheral nervous system disease 29.3 PRKN PMP22 CD40LG CD4 ANTXR2
33 miliary tuberculosis 29.2 CD40LG CD4
34 stomatitis 29.2 MX1 IFNA1 CD40LG CD4
35 viral infectious disease 29.2 MX1 IL2RA IFNA1 CD40LG CD4
36 cranial nerve disease 28.8 MARVELD1 LIPN CD40LG CD4 ANTXR2
37 facial nerve disease 27.1 MTRNR2L5 MARVELD1 LIPN HOXB1 FKBP4 CD40LG
38 facial palsy, congenital, with ptosis and velopharyngeal dysfunction 12.7
39 deafness, conductive stapedial, with ear malformation and facial palsy 12.5
40 recurrent peripheral facial palsy 12.4
41 congenital hereditary facial paralysis-variable hearing loss syndrome 12.4
42 aortic arch interruption, facial palsy, and retinal coloboma 12.3
43 anotia facial palsy cardiac defect 12.3
44 lyme disease 11.8
45 urofacial syndrome 1 11.6
46 facial paresis, hereditary congenital, 1 11.6
47 facial paresis, hereditary congenital, 3 11.5
48 orofacial granulomatosis 11.5
49 camurati-engelmann disease 11.5
50 lyme disease - neurological complications 11.4

Graphical network of the top 20 diseases related to Bell's Palsy:



Diseases related to Bell's Palsy
Sources

Symptoms & Phenotypes for Bell's Palsy

About this section

UMLS symptoms related to Bell's Palsy:


seizures, tremor, muscle weakness, generalized muscle weakness, back pain, ophthalmoplegia, pain, headache, hemiplegia, syncope, chronic pain, sciatica, vertigo/dizziness, sleeplessness, oral manifestations, facial paresis, facial palsy, upper motor neuron, facial palsy, lower motor neuron, hemifacial paralysis, flaccid muscle tone
Sources

Drugs & Therapeutics for Bell's Palsy

About this section

Drugs for Bell's Palsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 58)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
2
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
3
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
4
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
5 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
6
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
7
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
8
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
9
Cortisone Experimental Phase 4 53-06-5 222786
10 valacyclovir Phase 4
11 Antiemetics Phase 4
12 Gastrointestinal Agents Phase 4
13 Hormone Antagonists Phase 4
14 Autonomic Agents Phase 4
15 Anti-Inflammatory Agents Phase 4
16 Antineoplastic Agents, Hormonal Phase 4
17 glucocorticoids Phase 4
18 Hormones Phase 4
19 Methylprednisolone Acetate Phase 4
20 Neuroprotective Agents Phase 4
21 Protective Agents Phase 4
22 Neurotransmitter Agents Phase 4
23 Acetylcholine Release Inhibitors Phase 4
24 Neuromuscular Agents Phase 4
25 Botulinum Toxins Phase 4
26 Cholinergic Agents Phase 4
27 abobotulinumtoxinA Phase 4
28 Botulinum Toxins, Type A Phase 4
29 incobotulinumtoxinA Phase 4
30 Anesthetics Phase 4
31 Anesthetics, Local Phase 4
32 Anti-Arrhythmia Agents Phase 4
33 Sodium Channel Blockers Phase 4
34 Central Nervous System Depressants Phase 4
35 Diuretics, Potassium Sparing Phase 4
36
Dexamethasone Approved, Investigational, Vet_approved Phase 2, Phase 3 50-02-2 5743
37
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2, Phase 3 1177-87-3
38
tannic acid Approved Phase 2, Phase 3 1401-55-4
39
Benzocaine Approved, Investigational Phase 2, Phase 3 1994-09-7, 94-09-7 2337
40
Phenol Approved, Experimental Phase 2, Phase 3 108-95-2 996
41 Pharmaceutical Solutions Phase 2, Phase 3
42 BB 1101 Phase 2, Phase 3
43
Prednisone Approved, Vet_approved Phase 2 53-03-2 5865
44
Salicylic acid Approved, Investigational, Vet_approved 69-72-7 338
45
Miconazole Approved, Investigational, Vet_approved 22916-47-8 4189
46
Lapatinib Approved, Investigational Early Phase 1 231277-92-2, 388082-78-8 208908 9941095
47
Iron Approved, Experimental 7439-89-6, 15438-31-0 23925 27284
48
Acyclovir Approved Early Phase 1 59277-89-3 2022
49 Keratolytic Agents
50 Dermatologic Agents

Interventional clinical trials:

(show top 50) (show all 75)
# Name Status NCT ID Phase Drugs
1 A Multicentre Placebo-Controlled Evaluation of Prednisolone and/or Valaciclovir for the Treatment of Bell's Palsy Completed NCT00510263 Phase 4 Prednisolone + placebo;Valaciclovir + placebo;Prednisolone + valaciclovir;Placebo + placebo
2 Randomized, Single-blind Comparison of Three Commercially Available Botulinum Neuromodulators in the Management of Facial Synkinesis Completed NCT03048383 Phase 4 OnabotulinumtoxinA Injectable Product;AbobotulinumtoxinA Injectable Product;Incobotulinumtoxin A Injectable Product
3 The Facial Nerve Palsy And Cortisone Evaluation (FACE) Study in Children: A Randomized Double-blind, Placebo-controlled, Multicenter Trial Recruiting NCT03781700 Phase 4 Prednisolone;Placebo Oral Tablet
4 Mixed Methods Investigation of Chronic Facial Paralysis in Individuals With Synkinesis: Study of Outcomes Before and After Treatment Recruiting NCT04148872 Phase 4 Chemodenervation (4 months)
5 Study of the Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty Terminated NCT01833221 Phase 4 injection of 1% lidocaine, 2mL for facial nerve block
6 Assessment of Corticosteroid Effect in the Prevention of Facial Palsy After Cerebella-pontine Angle Surgery Completed NCT00438087 Phase 3 methylprednisolone
7 Intratympanic Steroid Injection for Treatment of Idiopathic Facial Nerve Paralysis Recruiting NCT03508440 Phase 2, Phase 3 Prednisone
8 Quadrant Parotidectomy Versus Superficial Parotidectomy for Treatment of Pleomorphic Adenoma Withdrawn NCT01607866 Phase 2, Phase 3
9 Prednisone Treatment for Vestibular Neuronitis Completed NCT00271791 Phase 2 Prednisone;Prednisone
10 Mimetic Interfaces - Toispuoleisen Kasvohermohalvauksen Kojeellinen Kuntoutus Terveen Puolen Lihasaktiviteettiohjauksella. Stimulaattorin Prototyypin Testaus terveillä koehenkilöillä ja Kasvohermohalvauspotilailla. Active, not recruiting NCT03496025 Phase 1
11 Surgery or Clinical Follow-up in Patients With Bell's Palsy. A Prospective, Parallell, Single Center, Randomized , Open Surgery Clinical Study. Unknown status NCT02179684
12 Study of Psychological Factors on the Occurence of Bell's Palsy Unknown status NCT01377766
13 Prednisone Acetate and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, Comparative Effectiveness Research in China Unknown status NCT01201642 Prednisolone
14 Lengthening Temporalis Myoplasty and Improvement of Primary Swallowing Disorders in Facial Paralysis Unknown status NCT03284125
15 The Safety of GSK Biological's H1N1 Pandemic Vaccine in Manitoba, Canada Unknown status NCT01421251
16 Quantification, Analysis and Simulation of Facial Mimics Movements Unknown status NCT02002572
17 Prospective Randomized Study Comparing Clinical, Functional and Aesthetics Results of "Classical" Pterional and Minipterional Craniotomies. Unknown status NCT01872741
18 Cognitive and Physical Functions in Patients With TIA. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event Unknown status NCT01509924
19 Studying of Acupuncture for Bell's Palsy According to Different Stages Completed NCT00608660
20 Microbiologic Findings of Acute Facial Palsy in Children Completed NCT01537952
21 Study of Effects of Deqi and Neuropsychological Factors on Acupuncture Effects in Treatment of Bell's Palsy Completed NCT00685789
22 A New Clinical Therapy for Bell's Palsy Completed NCT01686464 prednisone and valacyclovir treatments
23 Function and Form Outcomes in Patients With Facial Paralysis Completed NCT03974763
24 Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis Completed NCT03006783
25 Treatment Bell´s Palsy: Prednisone vs Prednisone Valacyclovir Completed NCT00561106 prednisone- valacyclovir;prednisone-placebo
26 The Role of MyotonPro in Assessing the Biomechanical Properties of Facial Muscles in Facial Paralysis Patients and Its Role in Monitoring Recovery Following Facial Reanimation Surgery Completed NCT02489162
27 Improvement of Facial Symmetry With Myofunctional Therapy Combined to Botulinum Toxin Injections in Long Standing Facial Paralysis Completed NCT00989209 Botulinum Toxin Type A
28 Pilot Study Assessing Cognitive Function and Emotional Possessing in Patients With Bilateral Facial Palsy Completed NCT02179450
29 Antiviral Treatment in Facial Palsy. Randomized Control Trial Completed NCT02328079 Steroids (Prednisolone) and Steroids plus Antiviral (Prednisolone + acyclovir)
30 Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial Paralysis Completed NCT00903669
31 Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors Completed NCT02527226
32 Neuro Occlusal Rehabilitation in Patient With Peripheral Facial Paralysis - a Randomized Clinical Trial Completed NCT01327157
33 A Phase IV Study to Assess the Safety of Menveo Vaccine Being Used by HMO Subjects Aged 11-21 Years of Age Completed NCT01452464
34 Complications in Parotid Surgery - a Prospective Cohort Study Completed NCT02486393
35 Non-surgical Correction of Eye Lid Paralysis With External Magnet Systems Completed NCT02988856
36 A New Predictor Marker for Cochlear Implants Infection: Neutrophil/ Lymphocyte Ratio Completed NCT04120181
37 Retrospective Clinical Outcome of Parotid Tumor Surgery Completed NCT01983176
38 Clinical Research Core Dental Screening Protocol Completed NCT00090818
39 Exploration of the Diagnostic Capabilities of Ultrasound of the Oropharynx and Larynx Completed NCT00001167
40 Validation of Prehospital Stroke Scale (FAST PLUS TEST) to Predict Patients With Large Arterial Vessel Intracranial Occlusion. Completed NCT03072524
41 Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinib in Vivo in Vestibular Schwannomas Completed NCT00863122 Early Phase 1 lapatinib
42 Assessment Effects of Somatosensorial and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke Completed NCT03477188
43 Iowa/Nucleus 10/10 mm and Nucleus Freedom Cochlear Implants Implanted Bilaterally in Children Ages 12-24 Months Completed NCT00594061
44 Pilot Clinical Trial to Study Facial Electrical Stimulation to Promote Recovery in Patients With Bell's Palsy and Poor Prognostic Factors Recruiting NCT03836989
45 Production et Perception émotionnelle Chez Les Patients paralysés Faciaux: Marqueurs Respiratoires, Phonatoires et expressivité Faciale. Recruiting NCT03619720
46 Effect of Laser Acupuncture Treatment on Chronic Facial Paralysis: A Randomized Sham Control, Double Blind Pilot Study Recruiting NCT03592797
47 Comparative Study of Peripheral Facial Paralysis Sequelae Based on the Initial Medical Care of Lyme Disease Among Children Recruiting NCT03981874
48 Reliability of Multislice Computed Tomography Scan in Cases With Facial Nerve Paralysis Due to Temporal Bone Trauma Recruiting NCT03469427
49 Electrical Stimulation to Improve Recovery After Peripheral Nerve Injury - A Randomized Controlled Prospective Study Recruiting NCT03996525
50 A Pilot Study Evaluating the Effectiveness of Information and Therapy Guides for Improving the Psychosocial Wellbeing of People With Facial Palsy. Recruiting NCT03943953

Search NIH Clinical Center for Bell's Palsy

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Scopolamine
Scopolamine Hydrobromide

Cochrane evidence based reviews: bell palsy

Sources

Genetic Tests for Bell's Palsy

About this section

Genetic tests related to Bell's Palsy:

# Genetic test Affiliating Genes
1 Facial Palsy 29
Sources

Anatomical Context for Bell's Palsy

About this section

MalaCards organs/tissues related to Bell's Palsy:

40
Eye, Bone, Testes, T Cells, Thyroid, Kidney, Myeloid
Sources

Publications for Bell's Palsy

About this section

Articles related to Bell's Palsy:

(show top 50) (show all 2410)
# Title Authors PMID Year
1
Antiviral treatment for Bell's palsy (idiopathic facial paralysis). 61 42
31486071 2019
2
Patterns of pontine strokes mimicking Bell's palsy. 61 42
31455262 2019
3
Increased risk of Bell palsy in patient with migraine: A longitudinal follow-up study. 61 42
31124964 2019
4
Etiology and therapy of delayed facial paralysis after middle ear surgery. 61
32008076 2020
5
The Utility of Facial Nerve Ultrasonography in Bell's Palsy. 61
31870206 2020
6
Factors Associated With Fast Recovery of Bell Palsy in Children. 61
31623512 2020
7
Evaluation of Factors Associated With Favorable Outcomes in Adults With Bell Palsy. 61
31971554 2020
8
Isolated peripheral-type facial palsy due to contralateral precentral gyrus cavernoma hemorrhage. 61
31982278 2020
9
Facial Weakness Analysis and Quantification Of Static Images. 61
31944968 2020
10
Implantable wireless device for study of entrapment neuropathy. 61
31626845 2020
11
A case of a facial nerve venous malformation presenting with crocodile tear syndrome. 61
31966922 2020
12
Variations in the management of acute Bell's palsy. 61
31610987 2020
13
Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis. 61
31910875 2020
14
Arachnoid bands and venous compression as rare causes of hemifacial spasm: analysis of etiology in 353 patients. 61
31754846 2020
15
Ramsay Hunt syndrome: characteristics and patient self-assessed long-term facial palsy outcome. 61
31982948 2020
16
Extrahepatic manifestations of hepatitis E virus: An overview. 61
31601068 2020
17
Misdiagnosing Bell's palsy as acute stroke. 61
31941750 2020
18
Short-Term Systemic Corticosteroids: Appropriate Use in Primary Care. 61
31939645 2020
19
Herpes viruses in optic neuritis: Similar to Bell's palsy. 61
31715425 2020
20
Pregnancy Does Not Increase the Risk of Bell's Palsy: A National Cohort Study. 61
31789796 2020
21
Is C-reactive protein to albumin ratio an indicator of poor prognosis in Bell's palsy? 61
31620889 2020
22
The effect of SJS Non-resistance Technique-Facial palsy on a patient with post-acute phase Bell's palsy unresponsive to conventional treatment: A case report. 61
31983540 2019
23
Significance of the Marginal Mandibular Branch in Relation to Facial Palsy Reconstruction: Assessment of Microanatomy and Macroanatomy Including Axonal Load in 96 Facial Halves. 61
31567417 2019
24
Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine. 61
31818534 2019
25
Concurrent Treatment With Intratympanic Dexamethasone for Moderate-Severe Through Severe Bell's Palsy. 61
31469789 2019
26
Prognostic Factors Associated With Recovery in Children With Bell's Palsy. 61
31390913 2019
27
Submental and Anterior Neck Originated Full-Thickness Skin Grafts for Periocular Procedures. 61
31743277 2019
28
Measurement of the depth of facial nerve at the level of stylomastoid foramen using MR imaging in Bell's palsy. 61
31228829 2019
29
Delayed recognition of emotional facial expressions in Bell's palsy. 61
31520847 2019
30
Facial Nerve Decompression for Bell's Palsy: An Endless Debate. 61
31575104 2019
31
Bell's Palsy in Pregnancy. 61
31755544 2019
32
The impact of misdiagnosing Bell's palsy as acute stroke. 61
31732591 2019
33
Course of Concomitant Bell's Palsy and Trigeminal Neuralgia Shortened with a Multi-Modal Intervention: A Case Report. 61
31104906 2019
34
Teaching Video NeuroImages: Cephalic tetanus: Not every facial weakness is Bell palsy. 61
31740518 2019
35
Clinical Implication of Facial Nerve Decompression in Complete Bell's Palsy: A Systematic Review and Meta-Analysis. 61
31487771 2019
36
Levator recession and minimal lateral tarsorrhaphy for the management of lagophthalmos and corneal exposure in facial palsy. 61
31601122 2019
37
Bell Palsy and the Risk of Cardio-Cerebrovascular Disease: A Population-Based Follow-Up Study. 61
30632167 2019
38
Autoimmune Bell's Palsy Following Immunotherapy For Metastatic Melanoma: A Report of 2 Cases. 61
31318723 2019
39
Differential diagnosis of peripheral facial nerve palsy: a retrospective clinical, MRI and CSF-based study. 61
31250103 2019
40
Recurrent Bell's palsy: outcomes and correlation with clinical comorbidities. 61
31708578 2019
41
The Diagnosis and Treatment of Idiopathic Facial Paresis (Bell's Palsy). 61
31709978 2019
42
Determining Etiology of Facial Nerve Paralysis With MRI: Challenges in Malignancy Detection. 61
31067979 2019
43
Clinician and Automated Assessments of Facial Function Following Eyelid Weight Placement. 61
31095257 2019
44
Chinese Herbal Medicine and Acupuncture Reduced the Risk of Stroke After Bell's Palsy: A Population-Based Retrospective Cohort Study. 61
31328958 2019
45
Electroneurography value as an indicator of high risk for the development of moderate-to-severe synkinesis after Bell's palsy and Ramsay Hunt syndrome. 61
31268392 2019
46
Celiac disease in the context of airborne allergen-associated chronic vulvo-vaginitis. 61
31599434 2019
47
CT and clinical prognostic factors in Bell's palsy: A study of 56 cases. 61
31220409 2019
48
High-dose Corticosteroids for Adult Bell's Palsy: Systematic Review and Meta-analysis. 61
31290805 2019
49
Immune-related gene expression profiles of hypothermia adipocytes: Implications for Bell's palsy. 61
31127963 2019
50
Correction to: Role of low-level laser therapy added to facial expression exercises in patients with idiopathic facial (Bell's) palsy. 61
31209586 2019
Sources

Variations for Bell's Palsy

About this section

ClinVar genetic disease variations for Bell's Palsy:

6 ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 46;XX;t(1;13)(q11.2;p11.2)dnTranslocation Uncertain significance 267932
Sources

Expression for Bell's Palsy

About this section
Search GEO for disease gene expression data for Bell's Palsy.
Sources

Pathways for Bell's Palsy

About this section

Pathways related to Bell's Palsy according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
NOD-like receptor signaling pathway 36
11.18 IFNA1 DEFA3 DEFA1 ANTXR2
Sources

GO Terms for Bell's Palsy

About this section

Biological processes related to Bell's Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 defense response to Gram-negative bacterium GO:0050829 9.5 DEFA3 DEFA1 CD4
2 intracellular estrogen receptor signaling pathway GO:0030520 9.4 DEFA3 DEFA1
3 mitochondrial fission GO:0000266 9.37 PRKN MX1
4 positive regulation of T cell proliferation GO:0042102 9.33 IL2RA CD40LG CD4
5 membrane disruption in other organism GO:0051673 9.26 DEFA3 DEFA1
6 defense response to virus GO:0051607 9.26 MX1 IFNA1 DEFA3 DEFA1
7 defense response GO:0006952 8.92 MX1 IFNA1 DEFA3 DEFA1
Sources

Sources for Bell's Palsy

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....